A retrospective chart review of Auryxia® (ferric citrate) in chronic kidney disease (CKD) patients on dialysis.
Phase of Trial: Phase IV
Latest Information Update: 01 Dec 2016
At a glance
- Drugs Ferric citrate (Primary)
- Indications Hyperphosphataemia; Kidney disorders
- Focus Pharmacodynamics; Therapeutic Use
- 01 Dec 2016 New trial record
- 18 Nov 2016 Results published in the Keryx Biopharmaceuticals Media Release
- 18 Nov 2016 Data from this study presented at the American Society of Nephrologys 2016 Kidney Week, as reported by a Keryx Biopharmaceuticals Media Release.